These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34748440)

  • 21. Comparative effectiveness of probiotic strains on the prevention of pediatric atopic dermatitis: A systematic review and network meta-analysis.
    Tan-Lim CSC; Esteban-Ipac NAR; Recto MST; Castor MAR; Casis-Hao RJ; Nano ALM
    Pediatr Allergy Immunol; 2021 Aug; 32(6):1255-1270. PubMed ID: 33811784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
    Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J
    J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
    Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
    Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotics for preventing gestational diabetes.
    Davidson SJ; Barrett HL; Price SA; Callaway LK; Dekker Nitert M
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD009951. PubMed ID: 33870484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of antiresorptive therapy on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials.
    Bassatne A; Bou Khalil A; Chakhtoura M; Arabi A; Van Poznak C; El-Hajj Fuleihan G
    Metabolism; 2022 Mar; 128():154962. PubMed ID: 34958816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral density.
    Fitzpatrick LA; Dabrowski CE; Cicconetti G; Gordon DN; Papapoulos S; Bone HG; Bilezikian JP
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2441-9. PubMed ID: 21593114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.
    Wells GA; Hsieh SC; Zheng C; Peterson J; Tugwell P; Liu W
    Cochrane Database Syst Rev; 2022 May; 5(5):CD004523. PubMed ID: 35502787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bisphosphonate use in children with cerebral palsy.
    Hurley T; Zareen Z; Stewart P; McDonnell C; McDonald D; Molloy E
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD012756. PubMed ID: 34224134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing estrogen-based hormonal contraceptives and hormone therapy on bone mineral density in women with premature ovarian insufficiency: a systematic review.
    Fine A; Busza A; Allen LM; Kelly C; Wolfman W; Jacobson M; Lega IC
    Menopause; 2022 Feb; 29(3):351-359. PubMed ID: 35213521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
    O'Donnell S; Cranney A; Wells GA; Adachi JD; Reginster JY
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005326. PubMed ID: 16856092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension.
    Ensrud KE; Barrett-Connor EL; Schwartz A; Santora AC; Bauer DC; Suryawanshi S; Feldstein A; Haskell WL; Hochberg MC; Torner JC; Lombardi A; Black DM;
    J Bone Miner Res; 2004 Aug; 19(8):1259-69. PubMed ID: 15231012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probiotics for maintenance of remission in ulcerative colitis.
    Iheozor-Ejiofor Z; Kaur L; Gordon M; Baines PA; Sinopoulou V; Akobeng AK
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD007443. PubMed ID: 32128794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
    Goldenberg JZ; Yap C; Lytvyn L; Lo CK; Beardsley J; Mertz D; Johnston BC
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD006095. PubMed ID: 29257353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-menopausal Osteoporosis and Probiotics.
    Huidrom S; Beg MA; Masood T
    Curr Drug Targets; 2021; 22(7):816-822. PubMed ID: 33109043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: a randomized placebo-controlled study.
    Leung JY; Ho AY; Ip TP; Lee G; Kung AW
    Bone; 2005 Feb; 36(2):358-64. PubMed ID: 15780963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probiotics for patients with hepatic encephalopathy.
    McGee RG; Bakens A; Wiley K; Riordan SM; Webster AC
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008716. PubMed ID: 22071855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alendronic acid produces greater effects than risedronic acid on bone density and turnover in postmenopausal women with osteoporosis : results of FACTS -international.
    Reid DM; Hosking D; Kendler D; Brandi ML; Wark JD; Weryha G; Marques-Neto JF; Gaines KA; Verbruggen N; Melton ME
    Clin Drug Investig; 2006; 26(2):63-74. PubMed ID: 17163237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
    Zhang ZL; He JW; Qin YJ; Huang QR; Liu YJ; Hu YQ; Li M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):129-33. PubMed ID: 16604479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.